Country | Type | Number | Dated | Case |
Hong Kong | Published Application | 40086212 | 08/18/2023 | 2020-066 |
Japan | Published Application | 2023-508362 | 03/02/2023 | 2020-066 |
China | Published Application | CN115698041A | 02/03/2023 | 2020-066 |
United States Of America | Published Application | 20230028178 | 01/26/2023 | 2020-066 |
European Patent Office | Published Application | 4081533 A0 | 11/02/2022 | 2020-066 |
Australia | Published Application | WO 2021/133829 | 07/01/2021 | 2020-066 |
Canada | Published Application | WO 2021/133829 | 07/01/2021 | 2020-066 |
Rep Of Korea | Published Application | WO 2021/133829 | 07/01/2021 | 2020-066 |
Mexico | Published Application | WO 2021/133829 | 07/01/2021 | 2020-066 |
New Zealand | Published Application | WO 2021/133829 | 07/01/2021 | 2020-066 |
Philippines | Published Application | WO2021/133829 | 07/01/2021 | 2020-066 |
Singapore | Published Application | WO 2021/133829 | 07/01/2021 | 2020-066 |
South Africa | Published Application | WO 2021/133829 | 07/01/2021 | 2020-066 |
UC Berkeley researchers have discovered a novel family of proteins denoted Cas12L within the Type V CRISPR Cas superfamily distantly related to CasX, CasY and other published type V sequences. These Cas12L proteins utilize a guide RNA to perform RNA-directed cleavage of DNA.
CRISPR, Cas12L